Aim: In developing African nations, late presentation and occurrence of complications
adversely affects survival. This study aims at identifying initial clinical and basic laboratory …

Introduction: Myelomatosis is a malignant proliferation of plasma cells in the bone marrow,
with relatively high prevalence in African populations. Variation in genetic mutations has …

PURPOSE Treatment patterns and survival outcomes of patients with multiple myeloma
(MM) in Kenya have not been adequately characterized. The objectives of this study were to …

Background: Multiple myeloma (MM) is a disease of the elderly with a median age at
presentation of 70 years. It is rare to diagnose MM in individuals less than 40 years and …

Multiple myeloma (MM) is a B-cell malignancy characterized by clonal proliferation of
terminally differentiated B lymphocytes. Rational use of proteasome inhibitors …

Objectives: To describe the musculoskeletalfeatures of multiple myeloma at presentation in
a tertiary health care centre in sub-Saharan Africa. Design: A Cross sectional observational …

Background Patients with multiple myeloma are being seen at an increasing frequency in
different indigenous African population. However, local data regarding the demographic …

Background: Multiple myeloma (MM) is the second most common blood cancer after
lymphomas, thereby accounting for 10% of all haematological malignancies. Objectives: To …

Background: Renal failure (RF) is a frequent complication during multiple myeloma (MM)
and sometimes reveals the disease. The median survival of MM patients with RF is shorter …

Contexte: Les atteintes rénales sont fréquentes au cours des gammapathies monoclonales
(GM) et leur persistance impacte la survie des patients. Notre objectif était de décrire ces …